Brian Giambattista - Varex Imaging President
| VREX Stock | USD 12.43 0.14 1.11% |
President
Dr. Brian W. Giambattista is Senior Vice President, General Manager Xray Detectors of the Company. He joined Varex after the acquisition of the PerkinElmer Medical Imaging business. He has nearly 30 years of experience in the industry, having held various management and engineering roles at PerkinElmer and General Electric, and received his doctorate degree in Physics from the University of Virginia. since 2017.
| Age | 65 |
| Tenure | 8 years |
| Professional Marks | MBA |
| Address | 1678 S. Pioneer Road, Salt Lake City, UT, United States, 84104 |
| Phone | 801 972 5000 |
| Web | https://www.vareximaging.com |
Varex Imaging Management Efficiency
The company has return on total asset (ROA) of 0.019 % which means that it generated a profit of $0.019 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0825) %, meaning that it created substantial loss on money invested by shareholders. Varex Imaging's management efficiency ratios could be used to measure how well Varex Imaging manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Varex Imaging's Return On Tangible Assets are fairly stable compared to the past year. Return On Equity is likely to rise to 0.08 in 2025, whereas Return On Capital Employed is likely to drop 0.05 in 2025. At this time, Varex Imaging's Non Currrent Assets Other are fairly stable compared to the past year. Return On Tangible Assets is likely to rise to 0.07 in 2025, whereas Total Assets are likely to drop slightly above 1.1 B in 2025.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Jim Stephens | Integer Holdings Corp | 51 | |
| Patrick Beyer | CONMED | 59 | |
| Stanley Peters | CONMED | 45 | |
| Terence Berge | CONMED | 54 | |
| Juergen Srega | Bruker | 70 | |
| Joseph Hauser | Orthopediatrics Corp | 43 | |
| David Bailey | Orthopediatrics Corp | 46 | |
| David Murray | CONMED | 77 | |
| Stanley III | CONMED | 49 | |
| Anthony Borowicz | Integer Holdings Corp | 67 | |
| D Lee | Artivion | 56 | |
| Jon Serbousek | Orthofix Medical | 63 | |
| Johonna Pelletier | CONMED | 51 | |
| Moshe Citronowicz | Apyx Medical | 72 | |
| Jason Garland | Integer Holdings Corp | 50 | |
| Tyler Lipschultz | Orthofix Medical | 58 | |
| Carlton Reckling | Si Bone | 63 | |
| Patrick Schmitz | Nevro Corp | 64 | |
| Christopher Christoforou | Nevro Corp | 50 | |
| Heather Cohen | CONMED | 51 | |
| Mark Munch | Bruker | 63 | |
Management Performance
| Return On Equity | -0.0825 | ||||
| Return On Asset | 0.019 |
Varex Imaging Corp Leadership Team
Elected by the shareholders, the Varex Imaging's board of directors comprises two types of representatives: Varex Imaging inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Varex. The board's role is to monitor Varex Imaging's management team and ensure that shareholders' interests are well served. Varex Imaging's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Varex Imaging's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Andrew Hartmann, Senior Detectors | ||
| Kimberley JD, General Officer | ||
| Shubham Maheshwari, CFO Officer | ||
| Kimberley Honeysett, Senior Vice President General Counsel, Corporate Secretary | ||
| Chad Holman, Chief VP | ||
| David Carmona, Vice Marketing | ||
| Christopher Belfiore, Director Relations | ||
| Stephen DeVita, VP Imaging | ||
| Mark Jonaitis, Senior Vice President & General Manager - X-Ray Sources | ||
| Karen Aranki, Chief Officer | ||
| Sunny Sanyal, President CEO, Director | ||
| Shaohua Liang, VP China | ||
| Brian Giambattista, Senior Vice President General Manager - X-ray Detectors |
Varex Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Varex Imaging a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0825 | ||||
| Return On Asset | 0.019 | ||||
| Profit Margin | (0.06) % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 897.36 M | ||||
| Shares Outstanding | 41.23 M | ||||
| Shares Owned By Insiders | 1.70 % | ||||
| Shares Owned By Institutions | 97.31 % | ||||
| Number Of Shares Shorted | 1.17 M | ||||
| Price To Earning | 33.13 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Additional Tools for Varex Stock Analysis
When running Varex Imaging's price analysis, check to measure Varex Imaging's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Varex Imaging is operating at the current time. Most of Varex Imaging's value examination focuses on studying past and present price action to predict the probability of Varex Imaging's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Varex Imaging's price. Additionally, you may evaluate how the addition of Varex Imaging to your portfolios can decrease your overall portfolio volatility.